Date:5/16/2012

r Patent for Influenza Vaccine Production II-136CSL Receives FDA Approval for Influenza Virus Vaccine II-136GlaxoSmithKline Inks Contract with UK Government II-137Merck & Co., Inc. and Dynavax to Jointly Develop Hepatitis BVaccine II-137Sanofi Pasteur Wins Contract to Design, Retrofit and MaintainInfluenza Vaccine Unit II-138Sanofi Pasteur Completes Construction of Influenza VaccineProduction Unit II-138Amgen Acquires Abgenix II-138Pfizer Acquires PowderMed II-139CancerVax and Micromet Merge to Establish Micromet, Inc. II-139Novartis Acquires Chiron II-139Dynavax Takes Over Rhein Biotech II-139AnGes and Vical Ink Collaborative Agreement II-139GeoVax Merges with Dauphin II-139Hawaii Biotech and Avantogen Merge to Form New Entity II-140CytoDyn Acquires Advanced Influenza Technologies II-140Emergent BioSolutions Acquires VIVACS II-140Acambis Divests Berna Business to Crucell II-140Novavax Inks an Agreement with Bharat Biotech to DevelopAvian Flu Vaccine II-140Aeras Receives License for Developing and DistributingTuberculosis Vaccine II-140Acambis to Supply Smallpox Vaccine to CDCP II-141AlphaVax and Wyeth Enhance Existing Licensing Agreement II-141Baxter Enters into a Contract to Supply Pandemic InfluenzaVaccine II-141Sanofi Pasteur Signs Stockpile Contract with the US Government II-141Crucell Licenses PER.C6® Technology to ADImmune Corporation II-142Baxter Wins Stockpile Production Contract for H5N1 from the NHS II-142Crucell Earns NIH Contract to Develop HIV Vaccine II-142Novartis Secures Stockpile Supply Contract from the USGovernment II-142Novartis Signs Distribution Agreement with Intercell II-142GSK Receives Stockpile Supply Contract for Fly Pandemic fromthe HHS II-143GSK Signs H5N1 Antigen Influenza Vaccine Contract withSwitzerland II-143DOR BioPharma Forms Alliance to Develop Ricin Vaccine II-143Nobilon and NVI to Jointly Develop RSV Vaccine II-144SciGen and OctoPlus Join Forces to Develop Hepatitis BVaccine Delivery II-144AlphaVax Receives Patent for
'/>"/>

SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)